This competing renewal seeks continued funding for The Jackson Laboratory's (TJL) Induced Mutant Resource (IMR) to continue to provide this critical resource of genetically engineered mice to the scientific community. Selectively altering the mouse genome by gene transfer (transgenic mice), homologous recombination and temporal- and tissue-specific gene mutation (gene targeting), and chemical mutagenesis is providing new and powerful tools for biomedical research. The production and use of such mice has rapidly expanded, increasing the need for resource centers to maintain, preserve, and distribute them at a high health status and as free from legal restrictions as possible. Researchers frequently receive so many requests for their mice that they must be relieved of the burden that distributing mice places on their research programs and grants. TJL has maintained and distributed mutant strains of mice for over 50 years. In 1992, TJL established the IMR whose purpose is to import, cryopreserve, and distribute biomedically important induced mutant mice. The need for the IMR is evidenced by its rapid growth. Since it began, the IMR has accepted >950 mutant stocks, of which >300 are still being distributed from the breeding colony. The remaining strains have been archived as frozen embryos or sperm. Another 120 are currently in the importation process. In the first 4.5 years of the current grant period, the IMR distributed >450,000 mice; in 2002 mice were distributed to 750 investigators and supported research funded by nearly every NIH categorical institute. We request support for rederivation, cryopreservation, and strain development to improve the scientific value of IMR strains; mice are maintained for distribution to other scientists on as much of a cost recovery basis as possible. To improve the IMR resource program we propose to do research to (1) develop more reliable methods of sperm cryopreservation and recovery, (2) characterize the tissue- and organ-specific expression of Cre-expressing strains by using appropriate reporter strains already present in the IMR, and (3) carry out further phenotype characterization of selected mutants to enhance their value. IMR acceptance of strains is coordinated with the NCRR-funded Mutant Mouse Regional Resource Centers (MMRRC), the National Cancer Institute Mouse Models of Human Cancer Consortium (MMHCC), and the European Mutant Mouse Archive (EMMA) to avoid duplication of resources.

National Institute of Health (NIH)
National Center for Research Resources (NCRR)
Animal (Mammalian and Nonmammalian) Model, and Animal and Biological Material Resource Grants (P40)
Project #
Application #
Study Section
National Center for Research Resources Initial Review Group (RIRG)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Jackson Laboratory
Bar Harbor
United States
Zip Code
Leiter, Edward H; Reifsnyder, Peter C; Wallace, Racheal et al. (2009) NOD x 129.H2(g7) backcross delineates 129S1/SvImJ-derived genomic regions modulating type 1 diabetes development in mice. Diabetes 58:1700-3
Davisson, Muriel T; Taft, Robert A (2006) Strategies for managing an ever increasing mutant mouse repository. Brain Res 1091:255-7
Petkov, Petko M; Cassell, Megan A; Sargent, Evelyn E et al. (2004) Development of a SNP genotyping panel for genetic monitoring of the laboratory mouse. Genomics 83:902-11
Sztein, J M; Noble, K; Farley, J S et al. (2001) Comparison of permeating and nonpermeating cryoprotectants for mouse sperm cryopreservation. Cryobiology 42:28-39
Sharp, J J; Linder, C C; Mobraaten, L E (2001) Genetically engineered mice. Husbandry and resources. Methods Mol Biol 158:381-96
Sztein, J M; Farley, J S; Mobraaten, L E (2000) In vitro fertilization with cryopreserved inbred mouse sperm. Biol Reprod 63:1774-80
Reifsnyder, P C; Flynn, J C; Gavin, A L et al. (1999) Genotypic and phenotypic characterization of six new recombinant congenic strains derived from NOD/Shi and CBA/J genomes. Mamm Genome 10:161-7
Sztein, J M; McGregor, T E; Bedigian, H J et al. (1999) Transgenic mouse strain rescue by frozen ovaries. Lab Anim Sci 49:99-100
Sztein, J; Sweet, H; Farley, J et al. (1998) Cryopreservation and orthotopic transplantation of mouse ovaries: new approach in gamete banking. Biol Reprod 58:1071-4
Christianson, G J; Brooks, W; Vekasi, S et al. (1997) Beta 2-microglobulin-deficient mice are protected from hypergammaglobulinemia and have defective antibody responses because of increased IgG catabolism. J Immunol 159:4781-92

Showing the most recent 10 out of 12 publications